The somatopause

Should growth hormone deficiency in older people be treated?

Steven Lieberman, A. R. Hoffman

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Secretion of growth hormone (GH) by the pituitary gland progressively declines beginning in early adult life, a phenomenon which is termed 'the somatopause'. The observation that many of the changes which occur with advancing age are opposite to the physiologic effects of GH suggests the declining levels of GH and insulin-like growth factor 1 (IGF-1), the mediator of many of the actions of GH, may be responsible for some of these changes. This article reviews the current understanding of mechanisms underlying the somatopause, the changes of aging which may result from diminished activity of the GH-IGF-1 axis, the evidence which suggests that GH 'replacement therapy' may reverse these changes, ad the risks of treating somatopause with GH replacement.

Original languageEnglish (US)
Pages (from-to)671-684
Number of pages14
JournalClinics in Geriatric Medicine
Volume13
Issue number4
StatePublished - 1997

Fingerprint

Growth Hormone
Somatomedins
Hormone Replacement Therapy
Pituitary Gland

ASJC Scopus subject areas

  • Geriatrics and Gerontology

Cite this

The somatopause : Should growth hormone deficiency in older people be treated? / Lieberman, Steven; Hoffman, A. R.

In: Clinics in Geriatric Medicine, Vol. 13, No. 4, 1997, p. 671-684.

Research output: Contribution to journalArticle

@article{c8c84fac8b0c4d50859c5c7cbb47637d,
title = "The somatopause: Should growth hormone deficiency in older people be treated?",
abstract = "Secretion of growth hormone (GH) by the pituitary gland progressively declines beginning in early adult life, a phenomenon which is termed 'the somatopause'. The observation that many of the changes which occur with advancing age are opposite to the physiologic effects of GH suggests the declining levels of GH and insulin-like growth factor 1 (IGF-1), the mediator of many of the actions of GH, may be responsible for some of these changes. This article reviews the current understanding of mechanisms underlying the somatopause, the changes of aging which may result from diminished activity of the GH-IGF-1 axis, the evidence which suggests that GH 'replacement therapy' may reverse these changes, ad the risks of treating somatopause with GH replacement.",
author = "Steven Lieberman and Hoffman, {A. R.}",
year = "1997",
language = "English (US)",
volume = "13",
pages = "671--684",
journal = "Clinics in Geriatric Medicine",
issn = "0749-0690",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - The somatopause

T2 - Should growth hormone deficiency in older people be treated?

AU - Lieberman, Steven

AU - Hoffman, A. R.

PY - 1997

Y1 - 1997

N2 - Secretion of growth hormone (GH) by the pituitary gland progressively declines beginning in early adult life, a phenomenon which is termed 'the somatopause'. The observation that many of the changes which occur with advancing age are opposite to the physiologic effects of GH suggests the declining levels of GH and insulin-like growth factor 1 (IGF-1), the mediator of many of the actions of GH, may be responsible for some of these changes. This article reviews the current understanding of mechanisms underlying the somatopause, the changes of aging which may result from diminished activity of the GH-IGF-1 axis, the evidence which suggests that GH 'replacement therapy' may reverse these changes, ad the risks of treating somatopause with GH replacement.

AB - Secretion of growth hormone (GH) by the pituitary gland progressively declines beginning in early adult life, a phenomenon which is termed 'the somatopause'. The observation that many of the changes which occur with advancing age are opposite to the physiologic effects of GH suggests the declining levels of GH and insulin-like growth factor 1 (IGF-1), the mediator of many of the actions of GH, may be responsible for some of these changes. This article reviews the current understanding of mechanisms underlying the somatopause, the changes of aging which may result from diminished activity of the GH-IGF-1 axis, the evidence which suggests that GH 'replacement therapy' may reverse these changes, ad the risks of treating somatopause with GH replacement.

UR - http://www.scopus.com/inward/record.url?scp=0031468826&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031468826&partnerID=8YFLogxK

M3 - Article

VL - 13

SP - 671

EP - 684

JO - Clinics in Geriatric Medicine

JF - Clinics in Geriatric Medicine

SN - 0749-0690

IS - 4

ER -